Recombinant adiponectin administration is sufficient to improve glucose, lipid, and insulin plasma levels as well as insulin receptor expression and liver steatosis in high fat diet-induced obesity mice treated with streptozotocin [62]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.